Senior lecturer with 14 year’s experience of HE teaching, predominantly Immunology and Cancer Biology. Supervised PhD completions in Cancer Biology, iPSC, and meningococcal vaccines.

Research interests are in Oncology, with a particular focus on Cancer Genetics, Cancer Biology, Immuno-Oncology and Pharmacognosy.

Professor Dr. Krassimir Metodiev, MD, Ph.D., DSc(Med), is Head of the Department of Preclinical and Clinical Sciences, Medical University, Varna, Bulgaria; President, IMAB; Vice-President, FESCI; Referent, UICC; and Director, ARW Bioterrorism, Scientific Affairs’ Division, NATO. His specialties are immunology and clinical microbiology. He has published 240 papers, IF 174.00, 7 books on medicine, and 2 books on poetry. He is editor in chief of the Journal of IMAB and editorial board member of IJIP, EJI, CEJM, JAA, and JISAO. He has attended 120 congresses worldwide, is a plenary speaker, and has been the chairperson of several sessions and workshops. He has been guest professor in Germany (Institute for Immunology, Munich); Austria (Danube University, Krems); Norway (The Norwegian Radium Hospital, Institute for Cancer Research, Oslo); and Israel (Hadassah-Jerusalem, Rambam-Haifa, Sheba-Tel Hashomer).

immunology, autoimmunity

Mr. Inderpaul Birdi is an experienced cardiothoracic surgeon in the United Kingdom. His specialist area of expertise is minimally invasive heart surgery where he has an international reputation. He works at The Wellington Hospital, The Harley Street Clinic, The Essex Cardiothoracic Centre and The Kent Institute of Medicine and Surgery. The Keyhole Heart Clinic was founded by Mr. Birdi to provide patients with information and clinical access to specialised minimally invasive cardiac therapies within the most prestigious Hospitals in the United Kingdom. The Clinic has developed strong links with The Harley Street Clinic and The Wellington Hospital. He is currently actively involved with many world-class clinicians in a wide array of clinical specialties tasked to develop international VIP clinical services in the United Kingdom. In his spare time he performs as a Tenor at various venues in London.

Minimally Invasive Heart Surgery, Mitral Valve Repair and Replacement, Aortic Valve Repair and Replacement, Tricuspid Valve Repair and Replacement, ASD Repair, Beating Heart Surgery, Coronary Artery Surgery, Treatment of Heart Rhythm Disorders,

Wissam N. Raad MD is a minimally invasive Attending Thoracic Surgeon at Mount Sinai Hospital, Mount Sinai Roosevelt and Mount Sinai St. Luke’s Hospitals. He holds an academic appointment as an Assistant Professor of Thoracic Surgery at The Icahn School of Medicine at Mount Sinai. Dr. Raad was born and raised in Beirut, Lebanon. He received his medical education at the Royal College of Surgeons in Ireland.Dr. Raad is active in several societies and organizations including the Society of Thoracic Surgeons, American College of Surgeons, Society of Gastrointestinal and Endoscopic Surgeons (SAGES), the New York General Thoracic Surgical Club, and the Royal College of Surgeons.

Cancer, Regeneration, Stem Cells in lung cancer

Dr. Sameer Gupta is an interventional Cardiologist in Metro Hospitals & Heart Institutes with a busy practice and perform more than 300 PCI's/PTCA's and 1500 coronary angiographies per year that include high risk procedures such as CTO's, bifurcation lesions, left main stents and PCI in patients on cardiogenic shock. Performed and trained in complex cardiac procedures including Coronary Angiography and Interventions (a procedure performed when patients have heart blockages), Left ventricular support devices). Certified by five American Boards - Internal Medicine, Cardiology, Interventional Cardiology, Echocardiography and Vascular Medicine. Member of the American College of Physicians, Member of American College of Cardiology, Member of American Heart Association and Lifetime Member of "Indian Federation of Sports Medicine"

Interventional Cardiology and Endovascular surgery

Khaled M. AlKattan is the Vice President for Administration and Finance and Dean of College of Medicine (Alfaisal University), Saudi Arabia. He is also the Professor and Senior Consultant of Thoracic Surgery.

Thoracic Surgery

Raed Tayseer Suleiman is the Vice President for Jordanian Thoracic Society and Medical Director of the Intensive Care Unit at Ibn Al Haytham Hospital, Jordan. He is also Consultant pulmonologist and sleep specialist in Jordan.

Pulmonary diseases

Professor Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Immunology, Vaccine, Oncology, Murine Virology, Antiviral Chemotherapy, Effects of inhibitors on viral replication, Studies on the role of herpesviruses in cancer, Tumor immunology, Pathology of AIDS

Osama O Ibrahim is a highly-experienced Principle Research Scientist with particular expertise in the fields of biochemistry, microbiology, molecular biology, and bioprocessing for both pharmaceutical and food ingredients. He was External Research Liaison for Kraft Foods with Universities for research projects related to bioprocessing and molecular biology. In the 2005, he accepted an early retirement offer from Kraft Foods and formed his own biotechnology company (Bio Innovation) providing technical and marketing consultation for new start-up biotechnology and food companies. He holds three bioprocessing patents and received his PhD in basic medical science (Microbiology, Immunology and Molecular biology) from New York Medical College. He is a Member of American Chemical Society, American Society of Microbiology, and Society of Industrial Microbiology since 1979.

Biotechnology, Immunology, Microbiology, Molecular Biology

Raul N Ondarza-Vidaurreta is a Professor of Biochemistry at Faculty of Medicine, UNAM and Medical Researcher at National Institute of Public Health, currently teaching Biochemistry and Molecular Biology and directing research theses in both Master’s and Doctor’s degree in the Faculties of Sciences and Medicine of the UNAM. He has published more than 50 scientific papers. He has completed his Postgraduate in Biochemistry, Glasgow University, Scotland, Great Britain and Doctor in Biology (Biochemistry) Faculty of Sciences, UNAM, Mexico and he was a Fellow of John Simon Guggenheim Memorial Foundation, Dr. Honoris Causa, Republique Francaise, Académie de Créteil, Universitè Paris XIII. He was a Visiting Professor at Scripps Institution of Oceanography, University of California, San Diego at La Jolla, California. For twelve years, Dr. Ondarza was Advisor and General Coordinator of Science Committees within CONACYT (1971-1982) and created five new research centers in several locations in Mexico dedicated to the fields of Ecology, Biomedical Research, Biotechnology, Chemistry, Marine Biology and Oceanography. These centers are CICESE in Ensenada, B.C.; CIBNOR in La Paz, B.C. Sur; CIES in San Cristóbal de Las Casas, Chiapas; CIQA in Saltillo, Coahuila; and CICY in Mérida, Yucatán.

Biochemistry, Molecular Biology, Epigenetics

Zlatko Dembic is a Professor of cell biology, immunology and microbiology at the Department of Oral Biology, University of Oslo.

Immunogenetics, Immunology, Cell Biology, Dental

Guixiu Shi has completed his PhD at University of Montreal, Canada, and finished his postdoc at The Trudeau Institute, USA. He is professor and Chair of the department of rheumatology and clinical immunology in The First Affiliated Hospital of Xiamen University. He serves as vice director of the professor committee in the medical school of Xiamen University. He has published more than 60 papers in peer-reviewed journals including JEM, Blood and JI. His research interest covers immune regulation and autoimmunity.

Rheumatology, Autoimmunity, Immune Regulation and Clinical Immunology

Frederic J. Deschamps is a Medical doctor (Lille- France University in 1990). He received his PhD at occupational Toxicology in the year of 1993. He was nominated professor of Medicine in 2002. He has improved for the last 20 years the department of occupational diseases of the university hospital of Reims (Champagne County). He manages for 1995 the Regional Institute of Occupational Health. He belongs to the French National University College of occupational Researches and Practionners. He has focused his work an occupational infectious diseases and health effects of low doses toxics with long term exposure.

Vaccine, Occupational Medicine, Pathology

Gaurisankar Sa completed his Ph.D from University of Calcutta and he finished his Post Doc at Cleveland Clinic, USA. He is a Senior Professor of Molecular Medicine Department, Bose Institute, Kolkata, India. He has published many articles in reputed journals and received many awards.

Biochemistry, Molecular biology, Cell signaling, Cancer biology, Tumor Immunology, Drug development

D.N Rao did his PhD in Organic Chemistry and later he joined AIIMS under Post-doctoral fellowship program and then became a full-fledged faculty member. At present, he is a retired Professor and Head of Biochemistry, AIIMS, New Delhi. He was selected as an emeritus scientist by ICMR. He has 38 years of experience in Teaching & Research and administration too. His Research expands from Immunology & Biochemistry of Leprosy, Malaria, HIV, Trauma hemorrhagic shock, Plague, Chikungunia , and dengu and finally Pre-mature ovarian failure & recurrent miscarriage in women. He received many National awards & orations for his research work and he has published extensively in peer review high impact factor international & national journals. He has guided large number of students for PhD, MD, MSc and M. Biotech.
He is a reviewer of manuscripts related to Immunology & Biochemistry, both national and international journals and member & chairperson for various advisory committees of ICMR, CSIR, DST, DBT, and AIIMS & UGC. Also, he is a selection committee member for faculty position, reviewer of thesis from various medical colleges & universities in India & abroad, He is an editorial member in many international journals and reviewer of projects of national & International collaborations in the areas of infectious diseases.
Currently he is the President of Indian Immunology Society & Vice President of FIMSA and member of many scientific organizations.

Biochemistry, Immunology, Infectious Diseases, Vaccine

Dipankar Nandi is a professor of Department of Biochemistry, IISc, Bangalore, India. He performed his doctoral studies at the University of California, Berkeley, USA on characterization of epithelial tissue associated T cells and was awarded the PhD degree in 1991. He was introduced to the world of protein degradation during his postdoctoral research at the University of Cincinnati, Ohio, USA while studying the composition and assembly of Interferon-γ-inducible proteasomes. He has published more than 60 scientific papers and he supervised 11 students for Ph.D., Dr. Nandi, is a reviewer for more than 10 international journals.

1) Studying novel microbial genes during stress, antibiotic resistance and infection 2) Understanding the host encoded immune responses

Horng-Dar Wang is a full Professor and the Director of Institute of Biotechnology and an adjunct Professor of the Institute of Systems Neuroscience at National Tsing Hua University in Taiwan. He received his PhD with honor in 1997 and worked as a postdoctoral fellow from 1997 to 1999 in Department of Molecular Pharmacology and Toxicology at University of Southern California, and as a postdoctoral scholar from 1999 to 2004 in Division of Biology at California Institute of Technology. He was an Assistant Professor in 2004, an Associate Professor in 2009, and promoted as a full Professor in 2015 in the Institute of Biotechnology at National Tsing Hua University.

Anti-Aging Molecular Genetic Research, Anti-Neurodegenerative and Anti-Cancer Gene

Dr. Kwon had his PhD from the Georgia Regents University, in 1981 and postdoctoral studies at the Department of Human Genetics, Yale University from 1981 to 1984. Dr. Kwon was a tenured Professor of the Indiana University School of Medicine, a Professor and Director of the Immunomodulation Research Center at the University of Ulsan, a Distinguished Professor and Investigator at the National Cancer Center, Korea, and Professor at the Department of Medicine Tulane University, New Orleans LA . He is currently the Founder and CEO of Eutilex who is developing T cell therapeutics and immunomodulatory antibody therapeutics. He has published over 300 peer-reviewed papers and has been serving as an editorial member of reputable journals.

Dr. Kwon’s research focuses on immunotherapy against cancers and autoimmune diseases. Dr. Kwon has established a concept called “inducible costimulation” by discovering 4-1BB-4-1BBL and AITR-AITRL systems. He has proved that immune functions can be selectively suppressed or enhanced through the inducible costimulation and presented the possibility of “selective immunotherapy”. Antigen-specific T cell therapeutics that Dr. Kwon’s team has developed are in phase 1 trials against various cancers in the NCC.

Pongsak Rattanachaikunsopon is a Professor in the Department of Biological Science at University Of Ubon Ratchathani, Thailand. He obtained Bachelor of Science in Radiological Technology at Mahidol University, Thailand and a Master of Science in Anatomy at Mahidol University, Thailand. He earned Ph.D. in Molecular Biology at Lehigh University, Pennsylvania USA. He has been awarded with Professor Sood Saengvichain Award for Best Research and Presentation in 13th Annual Meeting of the Society of Anatomy of Thailand in 1990, Professor Dr. Tab Nilanidhi Foundation Award for the outstanding graduate student in Anatomy in 1991 and Best Government Officer, The Ministry of Education in 2014. He is a member of Editorial Board of Journal of Herbal Medicine Research.

Molecular Biology, Microbiology, Biochemistry

Dr. Ivana Haluskova Balter, MD, specialised in infectious diseases, internal medicine covering various therapeutic axes, certified in Immunology and Pediatric, MBA vaccinology and years of clinical practise contributing to bring innovative science into clinical practise and support strategic global level partnership. Lived multi-country medical “field “experience in Southeast Asia (India in particular), West/Central/East Europe.
She can speak French, English, Russian, Italian, Czech, Slovak with notion of Mandarin.
Over 15 years of experience in pharmaceutical research and development for European and USA companies (Servier, Wyeth, Pfizer, Flamel) as Medical lead for various therapeutic areas for adults and children including neurodegenerative diseases, infectious diseases, metabolic diseases and orphan indications.
She is an active member of French immunology society (SFI) administrative board and Society of exotic pathology (France) and several international academic societies. Focus on innovation of R&D reflecting immunology and genetic interindividual and geographic variabilities and exploration of NCE originated from natural sources including traditional medicine.
She have years of experience to work globally within Europe, USA but recently more focused on BRICS - Asia (India in Particular) as a Medical advisor bringing new innovative concepts alive and getting them endorsed.

Immunology, Vaccine and Pediatric

Ishak Ozel Tekin received the Doctor of Medicine in 1993 from Gazi University Ankara, Turkey. He received the PhD degree in Immunology in Gazi University in 1999. In 2000, he moved to Zonguldak Karaelmas University where he founded the second department of immunology in Turkey the same year. He is the Head of Department of Immunology in Bulent Ecevit University, School of Medicine. He is mainly interested in inflammation and oxidative stress. He is a member of Turkish Immunology Society, Turkish Thorax Society, Turkish Association of Wound Care and Repair, European Respiratory Society, World Society of Interdiciplinary Anti-Aging Medicine. He is the scientific director of Immune-Aging Division of Regenera Research Group.

Immunology, Inflammation, Oxidative Stress

Dr. Sevgi Ciftci received her Ph.D. from the Microbiology of Medical Faculty at Istanbul University. She currently fellow as the Associate Professor in the Microbiology Department of the Faculty of Dentistry at Istanbul University. She is a member of the Editorial Board of several international journals. She also served as a member of the Organization Committee in International Congresses.

Virology (Especially hepatitis B virus and hepatitis C virus), Microbiology

Parichat Phumkhachorn is an Assistant Professor in the Department of Biological Science at Ubon Ratchathani University, Thailand. She has completed her Bachelor of Science in Medical Technology at KhonKaen University, Thailand and Master of Science in Microbiology at Mahidol University, Thailand. She received her Ph.D. in Biology at KhonKaen University, Thailand.

Medical Microbiology, Immunology

Professor Jamil has been a faculty member for 38 years. He holds several postgraduate degrees from England. In 1979, he joined Baghdad University, in 1997 immigrated to USA, in 1998 joined Wayne State University and in 2015 joined Michigan State University. He is a sole author of 18 books (8 academic) and first author of two, has wrote chapter in a book entitle “Biopsychosocial Perspective on Arab American: Culture, Development and Health”, 195 research publications, 252 scientific articles to the community people and has given 193 presentations at national & international meetings. He established three postgraduate programs in Occupational Medicine (Diploma, Master, and Ph.D.) at Baghdad University. In U.S., he participates in research funded by: Karmonas, NIH, NIEHS, Pfizer, Roche, and NIMH.). He was one of the founders of several scientific society: The Occupational Health & Safety Society in Iraq in 1985, the International Society of Iraqi Scientists" in 2000, and the Al Nahrain International Society of Iraqi Scientists (2017). Prof. Jamil biography, listed in the 25th. & 26TH. Dictionary of International Biography, Cambridge/England. He received 31 special awards from different academic institutions, non-profit organizations, WHO and governmental agency

Professor Jamil is interest to understand more about the impact of chemical air pollutions especially “war chemical” on the refugees especially veterans. His interest extend on study the impact of Hookah (Water pipe) on general population and also the impact of war trauma on immigrants in general especially refugees who immigrate from unstable countries.

Luiz Werber-Bandeira is the Head of clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro - General Hospital. He has a degree in Medicine, post-doctorate in Immuno-Genetics, and PhD in medicine-immunology-dermatology from Federal University of Rio de Janeiro-UFRJ. He is also specialized in Clinical Immunology-Allergy at the Federal University of Rio de Janeiro-UFRJ. Reorganizer of the clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro. Reorganizer of the immunology laboratory of the clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro. Creator, Scientific organizer and president of ImmunoRio in 97, 99, 2001 and 2004. President and scientific organizer of the extra section of clinical immunology 2006, 2007, 2008, 2010, 2015... Organizer and chair of the clinical immunology & chair of the South Fluminense-Vassouras faculty. Full professor in connected Domains-Carlos Chagas medical graduate school.

Clinical and experimental immunology, Allergy, Asthma

Anil Mishra is a Professor of Medicine. He is also the Director of Tulane Eosinophilic Disorder Center in the section of pulmonary diseases at Tulane University School Of Medicine. His research established that eosinophils are the resident cells of the gastrointestinal tract that home prenatally. He showed that eosinophil active chemokine eotaxin-1 constitutively expressed and has signifi cant role for eosinophils homing into the gastrointestinal tract. He developed the fi rst murine model of eosinophilic esophagitis (EoE). His fi ndings implicated aeroallergen in the etiology of EoE and suggested that esophageal eosinophilic infl ammation is mechanistically associated with pulmonary infl ammation. Recently, he reported that rIL-15 is a therapeutic molecule for the allergen-induced airway hyperactivity and fi brosis for chronic asthma and other pulmonary functional impairment. He is an Elected Fellow of American Academy of Allergy Asthma Immunology (FAAAAI) and American Gastrointestinal Association (FAGA). He has published over 72 articles, book chapters and reviews on molecular mechanisms of pulmonary and gastrointestinal allergic responses in high impact factor journals. His research is supported by National Institutes of Health via NIDDK and NIAID institutes. He is also a member of several NIH study sections and serving as Editor and Editorial Board Member in a number of international journals.

Pulmonary disease, Allergy

Gilbert Glady has completed his MD from Strasbourg University of Medicine and Postdoctoral studies from Besançon and Paris-Nord Universities of Medicine. He got an expertise in immunology and immunogenetics during all these years and developed interest for alternative medicines. So in 2010, he became Creator of the BI(G)MED method and Director of EBMA, the European association for training the medical profession at the BI(G)MED. He has participated in numerous international congresses in the fi eld of immuno-allergology, infectiology and oncology with posters and oral presentations

Immunology and Immunogenetics

R. P. Iyer, (Kris), Ph.D., FRSC is the co-founder and Chief Scientific Officer of Spring Bank Pharmaceuticals. He has more than 25 years’ experience in Biotechnology industry in drug discovery and development in diverse therapeutic areas including antivirals, inflammation and immune-oncology. Kris is a leading innovator in the fields of nucleic acid chemistry, bioorganic chemistry and pharmaceutical sciences with over 100 publications and 200 issued, as well as, filed US and international patents. Prior to Spring Bank, Kris was the co-founder and VP of Discovery of Origenix Technologies and also served as Associate Director of Antisense Discovery at Hybridon, Inc. He currently serves on the Board of Directors of Spring Bank Pharmaceuticals and is a member of the Scientific Advisory Board of Oligomerix, Inc., NY.

Cancer Immunology

Dr. Jerald C. Sadoff is currently the Head of Early Development of the Crucell Vaccine Institute which is the Center of Excellence for Vaccine Development for Johnson & Johnson Companies Worldwide. Dr. Sadoff has spent his entire career developing vaccines against a large number of bacterial, viral and parasitic diseases, 11 of which have been licensed for human use and several currently are in Phase IIB and Phase III clinical trials. He currently serves on several IPCAVD Scientific Advisory Boards for NIH sponsored HIV vaccine efforts and is on the NIAID AIDS Vaccine Research Working Group. Over the last 35 years, he has authored over 350 articles, book chapters, and abstracts and has 18 issued patents

Vaccine Development

Pierre A. MORGON is Chief Executive Officer of MRGN Advisors and Regional Partner for Switzerland at Mérieux Développement, an evergreen investment structure focused on medical devices, in vitro diagnostics and patient management services. He is also Chairman of the Board of Virometix since January 2017, a company developing proprietary synthetic nanoparticle platform in vaccines and immunotherapeutic drugs for viral diseases and cancer, as well as Non-Executive Director to the Board of Theradiag since March 2012, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, and Non-Executive Director to the Board of Eurocine Vaccines since December 2013, a company dedicated to developing nasal vaccines. He joined the board of Virometix as chairman in January 2017

Vaccines and Immunotherapeutic drugs for Viral diseases and Cancer

Benoit Tano, M.D. is a specialist, pioneer, and the Minneapolis area’s foremost expert in the field of Integrative Immunity. Dr. Tano is the founder of Integrative Immunity Health System, PC located in Edina, Minnesota. He is Johns Hopkins-fellowship trained in allergy and clinical immunology and authored the number one bestselling book, The Layman’s Guide to Integrative Immunity (2016). He combines his vast expertise in allergy and clinical immunology and in hormone imbalance syndrome to treat the root causes of 21st-century chronic diseases.

Clinical Immunology

Professor Andrzej K. Siwicki, VMD, Ph.D., DSc is a Head of Department Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury and Department of Pathology and Immunology IFI in Olsztyn, Poland. He is author of over 500 original papers in reputed journals and about 200 scientific communications (index-h 32, index of citation: 4502). His fields of interest are modulation of defence mechanisms and protection against diseases by natural and synthetic products in animals, influence of pollutants on the cell-mediated immunity and restoration of immunity after suppression induced by xenobiotics. Developed a new possibility in the comparative immunotoxicology for control of effect of xenobiotics and pharmaceutical products on the defence mechanisms and protection against diseases. He attended scientific missions in USA, Japan, France and Israel, was a co-ordinator of USDA and FAO projects and he is professor conferring of 14 PhDs and 4 DSc.

Microbiology and Clinical Immunology

1998-2003 Member of the Institut Universitaire de France Junior, then Honorary position 1998-2000 Senior Scientist at the Mind Body Institute of Harvard Medical School, USA 31/05/1995 Habilitation for directing research in Natural Sciences, University Lille 1 3/02/1993 Ph.D. in Life Science and Health, University Lille 1

Immunology

Prof. Dr. Ignat Ignatov was born on January 1, 1963 in the town of Teteven, Bulgaria. Тhe family Ignatov is from village of Gradina, region of Pleven, Bulgaria. In 1976 descrebes a phenomenon in which little apertures act like optic lenses. In 1989 Ignatov majored in physics from “Kliment Ohridski” Sofia University with master degree. In the same year he began his professional work in the sphere of medical biophysics. In 1996 he founded the Scientific and Research Center of Medical Biophysics (SRCMB) of which he is also an owner. Prof. Dr. Ignat Ignatov was a consultant of the National Center of Public Health (NCPH) at the Ministry of Health until 2003. The Bulgarian scientist is involved in research projects for the study of biophysical and medical effects in the application of alternative methodics for the influencing of human health. Bulgaria has a Health Act, which authorizes the practice of non-conventional (alternative) methodics. Trainings are carried out. From 2007 Ignat Ignatov is honorable doctor in European Academy of Natural Sciences (Germany). From 2013 he is Doctor of Science and Professor in The Russian Academy for Natural History. Prof. Ignatov is Chief Editor of two US journals. The first is Journal of Medicine, Physiology and Biophysics. The second is Journal of Health, Medicine and Nursing. The Bulgarian scientist is editor in chief in European Journal of Molecular Biotechnology, European Journal of Medicine - international bilingual scientific Journal and Research & Reviews in Biosciences.

Medicine, Physiology and Biophysics

He graduated from Hacettepe University Faculty of Medicine in 1990. He completed his specialist education in Hacettepe University Faculty of Medicine Internal Medicine Department in 1995 and his branch of Medical Oncology Unit in 1999. Associate Professor in 2000, Professor in 2007. Between 2004 and 2006, she worked as a guest lecturer at the MD Anderson Cancer Center in Houston, Texas, USA to study breast cancer. Hacettepe University Institute of Health Sciences in 2013 and Hacettepe University Cancer Institute in 2013-2016 and Hacettepe University Internal Medicine Department and Medical Oncology Department in 2013-2015.

Oncology

Sr. Research Associate at University of Texas Health Science Center at Houston Former Research Assistant at Baylor College of Medicine Former Research Assistant at New York Medical College

Epidemiolgy, Biochemistry

Dr. Luiz Werber-Bandeira is a physician with emphasis in Clinical Immunology, head of Clinical Immunology at the Santa Casa da Misericórdia Hospital and responsible for all the professional team that compose the clinical body of Imunoderm, in the Botafogo neighborhood and Ilha do Governador, Rio de January. For 36 years in the profession, he has done Post-Doctorate in Immuno-Genetics from the Oswaldo Cruz Foundation (FioCruz-RJ), a master's degree and a PhD from the Federal University of Rio de Janeiro (UFRJ). He is coordinator of the Postgraduate Course in Immunology and Clinical and Laboratory Allergy, organizer responsible for the Research Line of the Clinical and Experimental Immunology Unit of the Santa Casa da Misericórdia in Rio de Janeiro, as well as a professor who participates in the line of research in PhotoDermatology and Immunology of UFRJ.

PhotoDermatology and Immunology

Dr. Ahmed Shoker was born in Egypt, graduated from the University of Alexandria, Egypt and moved to Canada in 1981. He received his training in general medicine at the University of British Columbia, Vancouver, Canada. He received his training in nephrology and transplantation at the University of Toronto where he received his fellowship training in transplantation between 1987 and1990. He then moved to the University of Saskatchewan. Currently, he is a Professor of Medicine and Nephrology at the University of Saskatchewan. He is the Medical Director of the provincial Transplant Program. His research interests include clinical trials and basic research in the field of immunosuppression and inflammation.

His current interest is the relationship between cardiovascular disease risk factors and inflammatory markers before and after kidney transplantation

As a Professor of Clinical and Chemical Pathology with an MD degree from the Faculty of Medicine, Cairo University and as the current Head of the Electron Microscopic Research Department in the Theodor Bilharz Research Institute , a medical research institution affiliated to the Egyptian Ministry of Higher Education and Scientific Research I focus my research on the role of immune cells in combating hepatic diseases caused by helminthic (schistosomiasis), bacterial or viral infections (hepatitis virus ) using electron microscopy and immunoelectron microscopy to visualize cellular changes accompanying such diseases. I was involved in scientific cooperative research with German and French institutions and I am very open to different cultures. I speak fluent English, German, French, and Arabic.

I focus my research on the role of immune cells in combating hepatic diseases caused by helminthic (schistosomiasis), bacterial or viral infections (hepatitis virus ) using electron microscopy and immunoelectron microscopy to visualize cellular changes accompanying such diseases.

Qingxian Lu received his Bachelor's degree from Shandong University, Master's from Peking Union Medical College, Beijing, and Ph. D.The University of Texas.

His interests are focused on elucidating molecular mechanisms of three closely-related receptor tyrosine kinases, called Tyro3, Axl and Mertk (TAM), in the regulation of phagocytic activity in professional and non-professional phagocytes, particularly in the retinal pigmental epithelium cells in the eye. Phagocytic clearance of the spent photoreceptor distal outer segment (OS) tips by the retinal pigmental epithelium (RPE) cells is essential to maintain photoreceptor homeostasis. Failure of RPE phagocytosis of the OS leads to retinitis pigmentosa (RP). Mutation in the Mertk receptor tyrosine kinase causes photoreceptor degeneration. To understand the molecular role of Mertk in phagocytosis, we have used Mertk mutated RPE cells as a model to identify Mertk downstream target genes or signaling molecules that are involved in regulation of the phagocytic events.

Associate Professor Dr. Gamil G. S. Zeedan obtained Ph.D. Virology ,Cairo University Egypt , MVSCs Virology, Cairo University. BVSCs , Cairo University . 2015 up to date Assistant Professor of Microbiology and Virology at Clinical laboratory Sciences at College of Applied Medical Sciences Shaqra University Saudi Arabia,2014 -2015 Associate Professor of Microbiology at National Research Center Ministry of High Education - Cairo Egypt -Cairo Egypt, .10-2013 Assistant Professor of Microbiology at Faculty of Medicine and Applied Medical Sciences –Northern Border University (NBU)- KSA) for 3acdemic years 2007- 2010,Assistant Researcher at National Research Center- Ministry of High Education - Cairo Egypt. He teaching the following curriculum,Medical Microbiology and Virology, Diagnostic Microbiology ,Clinical Rotation of Microbiology and Clinical Rotation Immunology & Virology. 2015- up-to-date Microbiology at Clinical laboratory Sciences at College of Applied Medical Sciences Shaqra University Saudi Arabia . 2010-52013 Microbiology in faculty of Medicine and Applied medical Sciences - Northern Border University, Saudi Arabia. Participate in teaching Medical Microbiology ( Virology ) MICM 311 courses for 3rd-year Medical students (3 hours/week).Participate in teaching Diagnostic Microbiology

Microbiology and Virology

Thomas Böldicke, PhD, Helmholtz Centre for Infection Research, Department Structural and Functional Protein Research, Inhoffenstr. 7, 38124 Braunschweig, Germany

Immunology, Intracellular antibodies.

Thomas Grundström completed his doctorate at Umeå University in 1981 and his Medical degree in 1982. Dr. Grundström was post-doc 1982-1984 in the laboratory of prof. Pierre Chambon, Strasbourg, France, where he characterised the first discovered enhancer of transcription. He is professor at the department of Molecular Biology at Umeå University since 1994. Dr. Grundström discovered the first direct Ca2+/calmodulin inhibition of a transcription factor (Corneliusen et al., Nature, 1994) and has characterized the Ca2+ regulation of many regulatory proteins with a focus on the immune system. Dr. Grundström is presently studying regulation of production of high affinity antibodies

Immunology, Molecular Biology

Professor Lu’s research has focused on studying immune dysregulations in autoimmune diseases. During last ten years, his laboratory has been exploring novel strategies for the treatment of rheumatoid arthritis. His team was among the first to successfully treat autoimmune arthritis by targeting the cytokine B-cell activating factor in a preclinical study, which has significant therapeutic implications for the effective treatment of rheumatoid arthritis. Professor Lu is an internationally recognized expert in the field of autoimmunity. He is the Councilor of Federation of Immunological Societies of Asia-Oceania and has served as Chairman of Hong Kong Society for Immunology. He has published over 120 peer-reviewed papers in leading immunology and rheumatology journals.

Identification of genes involved in regulating lymphocyte development and function. Regulation of lymphocyte apoptosis in the quality control and homeostatic regulation. Gene silencing of novel TNF family cytokines for treating autoimmune disease.

Roswitha Gropp has over 25 years of experience in preclinical development and inflammatory diseases. She recently took on a different view considering the inflammatory process in UC as an uncontrolled wound healing process. This hypothesis assumes that epithelial damage induces the release of signals to evoke a Th2 characterized inflammatory response that ultimately results in repair of the colon. Using agent based modeling first disease maps were developed to describe the inflammatory milieu and the dynamics of the inflammatory response. This approach together with immunological profiling of patients allows for a better understanding of underlying mechanisms ultimately leading to individualized therapies.

Immunology

Charles J Malemud received the PhD from George Washington University in 1973 and completed postdoctoral studies at the State University of New York at Stony Brook in 1977. He is Professor of Medicine & Anatomy in the Division of Rheumatic Diseases and Senior Investigator in the Arthritis Research Laboratory at Case Western Reserve University School of Medicine. He has published more than 200 papers and reviews primarily in the field of chondrocyte biology. He is on the editorial board of several rheumatology, immunology and musculoskeletal journals and is Editor-in-Chief of the Journal of Clinical and Cellular Immunology.

Biology of the Musculoskeletal System Intracellular Signal Transduction Pathways Inflammation Pro-inflammatory, Anti-Inflammatory & Anabolic Cytokines Apoptosis Matrix metalloproteinases Osteoarthritis Rheumatoid Arthritis Fibromyalgia Autoimmune Disorders Research Interest

Sudhir Gupta is a Professor of Medicine, Pathology & Laboratory Medicine, and Microbiology & Molecular Genetics, Chief of the Division of Basic and Clinical Immunology, and the Director of the Jeffrey Modell Diagnostic Center in Primary Immunodeficiencies at the University of California, Irvine. He also serves as Director of Scientific Development at the Sass Foundation for Medical Research in New York. Dr Gupta received his medical and doctorate degrees from the King George's Medical College in Lucknow, India. Previous appointments include Associate Professor of Medicine and Immunology at the Weill Cornell Medical College, and Associate Member at the Sloan-Kettering Institute for Cancer Research, both in New York, New York. Dr Gupta is board certified in Clinical Immunology by the Royal College of Physicians and Surgeons of Canada; he is board certified in Allergy and Immunology, and Diagnostic Laboratory Immunology by the American Board of Allergy and Immunology. Dr Gupta is a Master of the American College of Physicians. Dr. Gupta has served on a number of committees for many leading governmental bodies and organizations, including the National Institutes of Health, the U.S. Food and Drug Administration, and the World Health Organization. Dr Gupta has made many original contributions in the field of cellular and molecular immunology as it relates to primary immunodeficiency diseases, AIDS, cancer research, and aging. These findings have been published in high-impact journals, including Science, Nature, the Proceedings of the National Academy of Sciences, the Journal of Experimental Medicine, the Journal of Clinical Investigation, the New England Journal of Medicine, and Aging Cell. Dr Gupta has published more than 500 scientific papers, invited reviews, and book chapters. He has edited 24 books in various areas of cellular, molecular, and applied immunology, including one on primary immunodeficiency.

Molecular signaling of apoptosis, Dendritic cell biology, B cell biology, Genetic basis of primary immunodeficiency diseases

Michael Tainsky is a molecular cell biologist who has been studying the molecular basis of human cancer for more than 30 years. In 1998, he came to the Karmanos Cancer Institute at Wayne State University School of Medicine after 13 years on the faculty of the University of Texas, M.D. Anderson Cancer Center in Houston, TX, and 8 years at NCI/NIH. He has studied the biological effects of oncogenes, tumor suppressor genes, and transcription factor on tumor cells; and in the Li-Fraumeni Cancer Syndrome, he studied the mechanisms of cellular immortalization. Recently, he extended his mechanistic cancer research to translational applications of genomics and proteomics to molecular diagnostics of ovarian cancer. For the past 10 years, his laboratory team has developed the epitope cloning technology and protein microarray immunoassays to detect tumor autoantibodies in patients’ sera. His Epitomics Biomarker Technology identifies the autoantigen biomarkers using novel informatics tools for the classification of patients. In 2009, he published a 330-page book as editor in the Methods in Molecular Biology Series from Humana Press entitled Tumor Biomarker Discovery. He was invited to guest edit Special Issues of the journal Cancer Biomarkers on Antibody Biomarkers and Biomarkers in Ovarian Cancer. Dr. Tainsky holds the Barbara and Fred Erb Chair in Cancer Genetics at the Barbara Ann Karmanos Cancer Institute. He is a professor in the Department of Oncology.

• Molecular genetic mechanisms by which normal cells become malignant • Pathway analysis of gene expression changes leading to cellular immortalization • Development of novel cancer diagnostic tests for early detection of cancer in the form of a complex blood test

Martin D’Souza has completed his PhD from the University of Pittsburgh, PA. He is the director of Graduate Programs at Mercer University, College of Pharmacy and Co-Director of the Center for Drug Delivery. He has published more than 80 manuscripts and is on the editorial board of several journals.

The D'Souza nanotechnology laboratory mainly focuses on the design of novel patented technologies to deliver nano vaccines via the oral, buccal, parenteral and microneedle based transdermal route. Examples include: viral vaccines such as influenza vaccines, HIV and human papilloma vaccines (HPV); bacterial vaccines such as pneumonia, meningitis, TB and typhoid; and cancer vaccines, such as breast, melanoma, prostate, liver and ovarian. Recently, we also have been involved in tissue bio-engineering- applications including the use of cell encapsulation and thermo-sensitive gels for transplantation of pancreatic cells in diabetes.

Ahmed Hegazi (or Ahmed Gaffer Hegazi; احمد جعفر حجازى) (born May 31, 1948) is currently a Professor of Microbiology and Immunology in the department of Zoonotic Diseases, National Research Center, Egypt. Prof. Hegazi received his masters degree in 1979, and his PhD in 1981. Hegazi's research work has been focused lately on bee products and their therapeutic effects. Hegazi Organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He has published 166 scientific papers and articles in national and international journals. He also served on the board of multiple national and international scientific journals. Dr. Hegazi is also the president of the Egyptian Environmental Society for Uses and Production of Bee Products, secretary of the Egyptian Society of Apitherapy, secretary general of the African Federation of Apiculture Associations, and a member of the International Apitherapy Commission (APIMONDIA). Awards First Class Decoration of Excellence, Egypt, 1995 The Senior Scientist Prize of National Research Center, Cairo, Egypt, 1996 The National Scientific Prize In Biological Sciences, Egypt, 1990 The Scientific Prize of The National Research Center, Cairo, Egypt, 1989 The Second Best Research Paper Award, International Congress of Propolis, Bones Airs, Argentina, 2000 Main Speaker Award,10th Academic Conference, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006 2 Bronze medals from The International Innovation Fair of the Middle East, Kuwait, 2007 Patents Patent No. 8901 at 22/08/2006: A novel drug from natural products with new therapeutic modalities in treatment of psoriasis Patent No. 1005 at 02/01/2006: A novel drug from natural resources for controlling Fascioliasis Patent No. 270: at 01/06/2005: A novel drug from medicinal plants with antiatherosclerotic (hypocholesterolaemic), antioxidant and cardio protective properties. Patent No. 272: at 01/06/2005: A novel drug from natural resources with antiatherosclerotic (hypocholesterolaemic), antioxidant and cardio protective properties. Scientific Activities Editor in the following International Journals: Research Journal of Allergy, 2007 International Journal of Virology, 2007 Current Research In Tuberculosis, 2007 Research Journal of Veterinary Science, 2007 Research Journal of Microbiology, 2007 International Journal of Cancer Research, 2007 Research Journal of Medicinal plants, 2007 Referee in the following International Journals: Journal of Planta Medica, 2005 Journal of Evidence Based Complementary and Alternative Medicine, 2006 International Journal of Radiation Biology, 2007

Apitherapy, Immunology

Hikmet Jamil has received his Medical degree from Baghdad University, MSc from London University and his PhD from Manchester University. He specializes in Occupational and Environmental Medicine. He has joined Michigan State University in 2015 after he left Wayne State University as an “Emeritus Professor”. He has published 20 books and 191 fi eld research articles. He has served as an international Visiting Lecturer and is one of the Founders of International Society of Iraqi Scientists and was elected in 2002 as its President until 2015. He has received several awards from academic institutions, non-profit organizations, the WHO and Governmental agencies.

Occupational and Environmental Medicine

Dr. Anil Mishra, PhD is Edward G. Schlieder Educational Foundation Endowed Chair and Professor of Medicine. He is also the Director of Tulane Eosinophilic Disorder Center in the Section of Pulmonary Diseases at Tulane University School of Medicine. Dr. Mishra's research established that eosinophils are the resident cells of the gastrointestinal tract that home prenatally (Mishra et al., J. Clin. Invest. 1999). He showed that eosinophil active chemokine eotaxin-1 constitutively expressed and has significant role for eosinophils homing into the gastrointestinal tract. He developed the first murine model of eosinophilic esophagitis (EoE) (Mishra et al., J. Clin. Invest. 2001). His findings implicated aeroallergen in the etiology of EoE and suggested that esophageal eosinophilic inflammation is mechanistically associated with pulmonary inflammation (J. Immunology 2002, and Gastroenterology, 2003). Most recently he reported that rIL-15 is a therapeutic molecule for the allergen-induced airway hyperactivity and fibrosis for chronic asthma and other pulmonary functional impairment. Dr. Mishra is an elected fellow of the American Academy of Allergy Asthma Immunology (FAAAAI) and the American Gastrointestinal Association (FAGA). He has published over 72 articles, book chapters and reviews on molecular mechanisms of pulmonary and gastrointestinal allergic responses in high impact factor journals. Dr. Mishra’ research is supported by The National Institutes of Health via NIDDK and NIAID institutes. Dr Mishra is also a member of several NIH study sections and serving Editor and Editorial Board member in a number of international journals.

Medicine, Pulmonology

Michael Roth is currently working as the Head of Pulmonary Cell Research, Pneumology, University Hospital Basel, Switzerland. He has completed his PhD from University of Basel. He has worked as a Visiting Professor and Associate Professor for University of Sydney for 2 years. He has published 148 articles in reputed journals.

Pulmonary Cell Research, Pneumology

Luiz Werber-Bandeira is the Head of clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro - General Hospital. He has a degree in Medicine, post-doctorate in Immuno-Genetics, and PhD in medicine-immunology-dermatology from Federal University of Rio de Janeiro-UFRJ. He is also specialized in Clinical Immunology-Allergy at the Federal University of Rio de Janeiro-UFRJ. Reorganizer of the clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro. Reorganizer of the immunology laboratory of the clinical and experimental immunology unit - Santa Casa da Misericórdia, Rio de Janeiro. Creator, Scientific organizer and president of ImmunoRio in 97, 99, 2001 and 2004. President and scientific organizer of the extra section of clinical immunology 2006, 2007, 2008, 2010, 2015... Organizer and chair of the clinical immunology & chair of the South Fluminense-Vassouras faculty. Full professor in connected Domains-Carlos Chagas medical graduate school.

Clinical and experimental immunology

Andrew Wilber has expertise in hematology and immunology. His laboratory is interested in understanding the role of the tumor microenvironment in suppressing anti-tumor immunity. Current efforts are examining deficiencies in natural anti-tumor immunity in patients with advanced kidney cancer. Specifically, his group is studying alterations in natural killer cells within the blood and tumor of these patients. These changes prevent natural killer cells from destroying kidney tumor cells. Prevention of these processes may be an important goal of future tumor therapy.

Tumor, Tumor Immunology

Young Kwang Chae is currently an Assistant Professor of Medicine, Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine & Co-Director of Developmental Therapeutics Program of the Division of Hematology Oncology. He is also an Co-Chair of Multi-Histology Disease Team Meeting, Robert H. Lurie Comprehensive Cancer Center. He won Many Awards such as Samsung Scholarship: tuition and living expense support for the Johns Hopkins University MPH program, October 2004 Johns Hopkins Bloomberg School of Public Health Student Conference Award, April 2006 First place, Clinical Research Award, Albert Einstein Medical Center, May 2009; for outstanding poster presented on the Research Recognition Day and many more

personalized cancer therapy, precision medicine, novel combination cancer therapy, targeted therapy, immunotherapy, biomarker studies, novel drug development, novel drug delivery systems, adaptive clinical trials design, cell signaling pathways, and immune checkpoint pathways.

Masoud H. Manjili is an Associate Professor in the department of Microbiology & Immunology in the VCU School of medicine, Massey Cancer center, USA. He obtained his PhD from Sydney University in 1996. He was also an affiliated member in Roswell Park Cancer Institute (2003-2004). He is an associate Editor of Journal Frontiers in Tumor immunology. Also an Editorial Board Member of Journal of Molecular & Genetic Medicine. He also serves as an Manaing editor of American Association of Immunologists; American Association for Cancer Research; Society for Immunotherapy of Cancer; Society for Thermal Medicine; American Association for the Advancement of Science; International Society of Translational Medicine.

Immunotherapy and cancer dormancy; Tumor Immunology; Tumor Immunoediting; Tumor Recurrence and Metastasis

In 2001, Dr. Han obtained his Ph.D degree in clinical hematology from Chinese PLA Postgraduate Medical School, and worked in Dept. of Molecule & Immunology of Chinese PLA General Hospital. In 2003, he did postdoctoral work at the University College London. In 2006, he was promoted to professor of molecular and cellular biology. Now, he is the Director of Dept. of Molecular and Cellular Biology, Director of Clinical Translational Ward, the General Hospital of PLA. Since 2001, he focused on mechanism research involved in cancer-treatment resistance and clinical translation of cell therapy. He has published over 80 articles.

Cancer- Treatment resistance, Clinical translation of cell therapy

Dr William Cho is a Biomedical Scientist in Queen Elizabeth Hospital. He is a Chartered Scientist granted by the Science Council (UK), a Registered Chinese Medicine Practitioner (HK), Guest Professor of a number of Universities and a Fellow Member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science and Hong Kong Society for Molecular Diagnostic Sciences. Dr Cho has published over 200 peer-reviewed papers. He serves as the editor-in-chief, editor and associate editor of a number of international medical journals. Dr Cho is also an international renowned grant reviewer of the Hope Funds for Cancer Research (USA), Cancer Research (UK), MRC Research Grant (UK), Health Research Board (Ireland), Science Foundation (Ireland), Istituto Toscano Tumori (Firenze), The Foundation Fournier-Majoie for Innovation (Brussels), National Medical Research Council (Singapore), The Medical Research Council (South Africa), and Academia Sinica Investigator Award (Taiwan), etc.

cancer, cancer diagnosis, treatment prediction and prognostication

Dr. Roza Nurieva is currently an Assistant Professor, Department of Immunology, Tenure-Track, The University of Texas MD Anderson Cancer Center, Houston, TX USA. She is also an Instructor, Department of Immunology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. she is honoured with an The Journal of Biological Chemistry/Herbert Tabor Young Investigator Award, International Cytokine and Interferon Society in 2015 & also published many articles in reputed journals.

Cancer, Immunology, Autoimmunity.

Dr Manal Mohamed Saber, has earned her PhD from Nottingham, UK. she is focusing on cancer studies, EMAP II, immune suppression, molecular, cellular and laboratory techniques at a high level. She received excellent training in molecular and cellular techniques at the highest international level and has previously worked with cancer and immunology studies. Her dedication to cure cancer got her involved in cancer studies

Cancer, Immunology, Cellular Immunology, Molecular Immunology

Professor Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

Murine Virology, Antiviral Chemotherapy, Immunology, Effects of inhibitors on viral replication, Studies on the role of herpesviruses in cancer, Tumor immunology, Pathology of AIDS.

Dr. Michael G Hanna, Jr. received his PhD in experimental pathology and immunology from the University of Tennessee (TN, USA) in the 1960s. He was a consultant with NASA for the lunar receiving laboratory during Apollo 11 and 12, for which his expertise in immunology was used in the testing of the lunar core powder for immunogenic or pathogenic materials. Dr. Hanna served during 1974–83 as Director of the National Cancer Institute, Frederick Cancer Research Center (MD, USA).

He was Chief Operating Officer during 1985–94 of Organon Teknika/Biotechnology Research Institute and Senior Vice President of Organon Teknika Corporation, a subsidiary of Akzo Nobel, Netherlands. He developed and obtained approvals for TICE BCG for the treatment of carcinoma in situ (CIS) bladder cancer, which remains the standard of care for prophylaxis of recurrence of superficial bladder cancer and therapy of CIS. Subsequently, Dr. Hanna founded PerImmune Inc., for which he served as President and Chief Executive Officer before it merged with Intracel Corp. in 1998. He continued to work for Intracel Resources as Chief Scientific Officer and Chairman.

In 2007, Dr. Hanna founded Vaccinogen Inc., where he served as Chairman and CEO. Currently, Dr. Hanna is Chairman Emeritus. The company is a pioneer in the field of cancer vaccines and is developing OncoVAX, an autologous vaccine designed to elicit a specific immune response against cancer cells. The Phase 3 vaccine is being investigated for treatment mainly of colon cancer, but also for melanoma and renal cell carcinoma.

In addition to cancer therapy research and development, Dr. Hanna has been involved in Homeland Security. He served as Chairman of the Department of Commerce Biotechnology Advisory Committee (1984–9) and also participated in the Department of Defense Technical Working Group for Biotechnology (1988–9). PerImmune completed a Department of Defense contract to manufacture the current effective therapeutic for Botulinum toxin, an equine heptavalent anti-toxin. Dr Hanna’s research resulted in over 225 publications in international peer-reviewed journals and book chapters, and he holds 10 patents related to immunotherapy. Dr Hanna has been the recipient of numerous honors and awards and has served on many editorial boards, including for Human Vaccines & Immunotherapeutics.

Cancer Vaccines, Active Specific Immunotherapy, Humoral Immunity, Tumor Antigens.

Yaffa Mizrachi Nebenzahl has completed her PhD at The Weizmann Institute, Israel in 1985. She is the Head of the Molecular Microbiology Laboratory in The Shraga Segal Department of Microbiology, Immunology and Genetics at the Faculty of Health Sciences in Ben Gurion University of the Negev, Israel.

Immunology, molecular biology, infectious diseases, bio chemistry, pneumonia, innate Immunity.

Dr. Jessy Deshane is currently an Associate Professor of Medicine at UAB. Since starting her own laboratory in January 2011, she focused her laboratory research program on immune regulation by myeloid-derived regulatory cells (MDRCs) in chronic inflammatory lung diseases. Dr. Jessy team have recently identified and characterized these free radical producing myeloid-lineage cells as master regulators of allergic airway inflammation. Her laboratory is particularly interested in delineating mechanisms underlying the differentiation and function of MDRCs in the establishment and resolution of inflammation. They are currently investigating the novel hypothesis that MDRCs can produce neo-antigens that trigger dysregulated immune responses in asthma. The impact of environmental exposures on MDRCs and generation of neo-antigens is also of great interest to her lab. She has recently extended her program to investigate novel strategies to target immunosuppression by myeloid-lineage cells and to reprogram the metabolism in the tumor microenvironment. Her team anticipates that their strategies will enhance persistent memory response for lung cancer.

Immune regulation, Asthma, Molecular Immunology, Tumor, Cancer

Dr. Rao is a professor of Microbiology, Parasitology, Immunology , Pharmacology and Epidemiology in many universities, many medical colleges in India, China, Nepal, Libya, and Philippines. Currently he is working as professor of Microbiology, Parasitology, Immunology and Dean of Student Affairs at Avalon University School of Medicine, Curacao, Netherland Antilles. Dr. Rao has more than 44 years of teaching and research experience. Supervised 4 students for Ph.D,. Authored 18 text books. 3 Universities appointed as their adviser . Presented 18 full length papers exclusively during 2015 to 2016 in different international journals. Accepted as organizing committee member for 3 international conferences in 2016. Invited Key note speaker and speaker for many conferences, universities and colleges. The Royal Society United kingdom awarded me three fellowships in 2016 for my current advanced research in Medicine. Dr Rao is post doctoral supervisor too. Dr Rao,is Editor -in chief and Editor for more than 12 international journals.

Parasitic infections are more in tropical countries and cause global health problem especially in developing countries, Advanced diagnostics, tests, vaccines, therapeutics and development of new drugs are needed. Viviparity is common among est mammals but not many provide long gestation period, To study long term parasitic toxic effects, it is essential to use long gestation period laboratory animal models. Rats have 21 days, rabbits 30,dog 60 days of gestation period, The subtle effects of Thalidomide tragedy resulting in phocomalia, apoda etc in the offspring lead to untold miseries, Similarly good number of cases of fetal deaths, still births, teratogenices etc. Dr.Rao used scorpion as model in estimation of heavy metals like mercury and lead in embryonic development of scorpion and noticed similar effects, Indeed great challenges, given that most drugs in pipe line failed in clinical trails. Because most of the drugs tested on low gestation period animals, A new thought in the drug design for parasitic diseases by using scorpion as a model. Introducing parasite in scorpion and observing the drug effects and reversal effects, In addition to clinical work, developed a variety of basic and transnational research programs, participated to Ph.D. programs.

Eugenio Luigi Iorio is an eclectic medical doctor with many different field of interest, he did doctorate in Biochemical Sciences. He is the president of International Observatory of Oxidative Stress (Salerno, Italy). According to his research, the identification and the control of oxidative stress, an emerging health risk factor related to the dysregulation of redox systems, may play a relevant role in the prevention and treatment of life-style related disorders. After 15 years of research he funded in 2007 the International Observatory of Oxidative Stress (IOOS), a no-profit scientific network of more than 3,000 researchers living in 35 different Countries, which main goal is to translate into the clinical practice the basic knowledge on free radicals and antioxidants as the ancient modulating mechanism of all living functions. As the President of IOOS Iorio promotes and realises worldwide programs aimed to improve or to maintain the quality of life through personalised interventions on life-style, by using the redoxomics approach that allows to measure the level of oxidative stress even in real time.

Oxidative Stress, Biochemistry

Ishak Ozel Tekin received the Doctor of Medicine in 1993 from Gazi University Ankara, Turkey. He received the PhD degree in Immunology in Gazi University in 1999. In 2000, he moved to Zonguldak Karaelmas University where he founded the second department of immunology in Turkey the same year. He is the Head of Department of Immunology in Bulent Ecevit University, School of Medicine. He is mainly interested in inflammation and oxidative stress. He is a member of Turkish Immunology Society, Turkish Thorax Society, Turkish Association of Wound Care and Repair, European Respiratory Society, World Society of Interdiciplinary Anti-Aging Medicine. He is the scientific director of Immune-Aging Division of Regenera Research Group.

Immunology, Inflammation, Oxidative Stress

Dr. Fenniri was educated at the University of Louis Pasteur in Strasbourg, France and received his undergraduate degree in chemistry and biochemistry (1989, top of his class) and his M.Sc. /Ph.D. degrees in supramolecular science and engineering (1990/1994) under the supervision of Professor Jean-Marie Lehn (Nobel Laureate). He then joined the Scripps Research Institute in California, USA, where he carried out his postdoctoral training under the supervision of Professor Richard A. Lerner (President and CEO). In 1997 he moved to Purdue University, where he initiated his independent academic career, and established the Purdue Laboratory for Chemical Nanotechnology (1999). In 2003, He joined the National Research Council and the University of Alberta to build and lead the Supramolecular Nanoscale Assembly program, and contribute to the shaping of the National Institute for Nanotechnology (NINT), its research programs and facilities, and the recruitment of highly qualified personnel. NINT has since grown from 4 principal investigators in 2003 to a vibrant research and technology organization of over 350 researchers in 2013.

In addition Dr. Fenniri held a full professor position with the Department of Chemistry (since 2003-2013) and adjunct full professor positions with the department of biomedical engineering (since 2010) with the faculty of medicine and with the department if Chemistry (since 2013) at the University of Alberta. Dr. Fenniri is currently Professor Chemical and Biomedical Engineering at Northeastern University, Boston, MA, USA.

Dr. Fenniri has achieved international recognition as a leader in the areas of self-assembly, supramolecular chemistry, nanomedicine, combinatorial chemistry, and materials sciences. His group works at the forefront of basic and applied nanosciences, in collaboration with various academic institutions, federal laboratories, and with the private sector. Dr. Fenniri’s contributions appeared in over 190 publications, 8 patents, and over 400 contributed national and international conference papers. Dr. Fenniri has also presented his work in over 150 invited distinguished lectures, colloquia and seminars around the globe. His research programs are supported by the Natural Science and Engineering Research Council of Canada, Alberta Advanced Education and Technology, the US National Institutes of Health, the National Research Council of Canada, the University of Alberta, and several private, provincial and federal funding organizations.

Dr. Fenniri is the recipient of several academic and professional honours and awards, including the Xerox UAC Award (2006–2008), the 3M Faculty Award (2000, 2002), the Showalter Trust Fund Award (1999, 2001), the Trask Trust Fund Technology Innovation Award (2000), the Cottrell Teacher Scholar Award (2000–2005), and the US National Science Foundation Career Award (1999–2003). Dr. Fenniri is Member of the Editorial Board of several scientific journals and serves on several national and international scientific boards, panels, and committees.

Nanotechnology for biomedical applications, Nanoscale materials for drug delivery, Cell therapeutics and regenerative medicine.

For more than 10 years is working actively to endocrine and metabolic diseases in prostate cancer at the Department of Medicine and Science of Aging of University G. d\'Annunzio of Chieti-Pescara, Italy. In particular, recently her research work has been awarded by the Italian Society of Urology, analyzing the complex relationship between changes in bone metabolism, renal function and immune structure in prostate cancer. She is currently a professor at the Postgraduate School of Urology at the University G. D'Annunzio of Chieti-Pescara. She also founded in 2015 at the People's University Nicholas Copernicus the Department of Urologic Sciences, Biomedical and Translational, of which She is a Director.

Simona Di Francesco research interest is in Urological Cancer and Immunology, Prostate and Immunology, Bladder and Immunology, Kidney and Immunology.

Noah Isakov is a Professor of Immunology and Chair of The Shraga Segal Department of Microbiology and Immunology at the Faculty of Health Sciences Ben Gurion University of the Negev Beer Sheva Israel. He received his PhD from the Weizmann Institute of Science in Rehovot Israel 1981 and performed postdoctoral studies at the University of Minnesota in Minneapolis MN 1981-1983 and the Scripps Research Institute in La Jolla CA 1983-1987. He performed a Sabbatical at the National Institute of Allergy and Infectious Diseases at the NIH Bethesda MD 1993-1995 and served as an Esther Z Greenberg Honors Chair in Biomedical Research at the Oklahoma Medical Research Foundation in Oklahoma City OK 2003-2004 and President of the Israel Immunological Society 2004-2006.

Immunology, signal transduction, biochemistry, cellular and molecular biology.

Burak Karacaören received his B.Sc. degree in Animal Science (Faculty of Agriculture) and M.Sc. in Biometry and Genetics (Institute of Natural Sciences) from Akdeniz University, Antalya, Turkey in 1999 and 2001 respectively. He spent 6 months in As, Agricultural University of Norway, Norway about animal production and statistics. He received his Dr.Sc.degree in Statistical Animal Genetics Group (Institute of Animal Sciences) from Swiss Federal Institute of Technology Zurich (ETH Zurich), Switzerland at 2006. As a part of his doctorate studies he spent 2 months in INRA Paris, France. He was a post doctoral researcher at the Roslin Institute, University of Edinburgh, Scotland, UK in Genetics and Genomics department and at the Laurentian Forestry Institute, University of Laval, Quebec, Canada in forestry genomics in 2008-2010 and 2010-2011 respectively. Currently he is an assistant professor in Biometry and Genetics Section, Department of Animal Science at Akdeniz University, Turkey.

Burak Karacaoren main research interests are in statistical methods applied to genetics, genomics and animal breeding.